Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of DHA on Anemia-inflammation in Hemodialysis Patients
NCT04536636Completed
- Start
- Jun 2018
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of docosahexaenoic acid in chronic kidney disease (CKD) and anemia (2 arms). Primary endpoint: Erythropoiesis-Resistance Index at 8 weeks. Started Jun 2018; status: completed.
02
Drugs
docosahexaenoic acid
03
Conditions
chronic kidney disease (CKD)anemia
Beyond the preview
Go deeper on NCT04536636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04536636.